Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Central South University(Medical Sciences) ; (12): 443-446, 2007.
Artigo em Chinês | WPRIM | ID: wpr-813864

RESUMO

OBJECTIVE@#To investigate the efficacy and security of different uses of propofol on the sedation during the upper gastrointestinal endoscopic procedures.@*METHODS@#Four hundred patients who underwent gastroscopy received midazolam and propofol as sedation. Patients were divided to 4 groups with different intervals between midazolam and propofol: Group A and D with the interval of 30 seconds to 1 minute, Group B and C with 3 to 5 minute interval. All patients were premedicated with midazolam and propofol at 16 approximately 25 mg/10s (Group A and B) and 6 approximately 7 mg/10s (Group C and D).@*RESULTS@#The doses of propofol of Group A,B,C, and D were (111.90+/-22.43),(102.20+/-15.99),(73.05+/-13.08) and (80.90+/-17.36)mg respectively, with significant difference(P<0.01). The time of return to consciousness decreased markedly in Group C and D [(9+/-1), (10+/-2)min ], and that of Group A and B was [(14+/-5), (13+/-3)min ]. There was significant difference between Group C, D and Group A, B(P<0.01).@*CONCLUSION@#The dose of propofol and the time of return to consciousness depend on the rate of administration and the interval between midazolam and propofol. Appropriate rate and interval can produce safer and more effective sedation for the upper gastrointestinal endoscopic procedure.


Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Feminino , Humanos , Masculino , Relação Dose-Resposta a Droga , Endoscopia do Sistema Digestório , Métodos , Hipnóticos e Sedativos , Infusões Intravenosas , Midazolam , Propofol , Fatores de Tempo
2.
Journal of Central South University(Medical Sciences) ; (12): 383-386, 2006.
Artigo em Chinês | WPRIM | ID: wpr-813692

RESUMO

OBJECTIVE@#To investigate the effect of prostaglandin E1 (PGE1) on the expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in experimental liver fibrosis rats.@*METHODS@#The liver fibrosis model was established by carbon tetrachloride. Rats were divided into a control group and PGE1-treated group. The pathological changes of the liver tissue from the two groups, the semi-quantitative analysis of hepatitic activity in HE stain sections, the pathological image quantitative analysis of the fibrosis degree, TIMP-1 positive cells, and the content of collagen were synthetically analysed.@*RESULTS@#The mark changes of liver pathology in HE stain sections were that the degree of hepatitic activity in the PGE1-treated group was obviously lower than that in the control group (P < 0.05). The fibrosis degree, TIMP-1 positive cells and the collagenous fibers decreased in the PGE1-treated group (P <0.05).@*CONCLUSION@#PGE1 has an anti-hepatofibrosis effect in the experimental rats, the inflammation of liver is light, and the proliferation of collagenous fibers can be restrained, whose mechanism is probably associated with the suppression of TIMP-1 expression caused by PGE1.


Assuntos
Animais , Feminino , Masculino , Ratos , Alprostadil , Farmacologia , Tetracloreto de Carbono , Intoxicação por Tetracloreto de Carbono , Cirrose Hepática Experimental , Metabolismo , Distribuição Aleatória , Ratos Wistar , Inibidor Tecidual de Metaloproteinase-1 , Genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA